Benavent, E.; Morata, L.; Escrihuela-Vidal, F.; Reynaga, E.A.; Soldevila, L.; Albiach, L.; Pedro-Botet, M.L.; Padullés, A.; Soriano, A.; Murillo, O.
Long-Term Use of Tedizolid in Osteoarticular Infections: Benefits among Oxazolidinone Drugs. Antibiotics 2021, 10, 53.
https://doi.org/10.3390/antibiotics10010053
AMA Style
Benavent E, Morata L, Escrihuela-Vidal F, Reynaga EA, Soldevila L, Albiach L, Pedro-Botet ML, Padullés A, Soriano A, Murillo O.
Long-Term Use of Tedizolid in Osteoarticular Infections: Benefits among Oxazolidinone Drugs. Antibiotics. 2021; 10(1):53.
https://doi.org/10.3390/antibiotics10010053
Chicago/Turabian Style
Benavent, Eva, Laura Morata, Francesc Escrihuela-Vidal, Esteban Alberto Reynaga, Laura Soldevila, Laia Albiach, Maria Luisa Pedro-Botet, Ariadna Padullés, Alex Soriano, and Oscar Murillo.
2021. "Long-Term Use of Tedizolid in Osteoarticular Infections: Benefits among Oxazolidinone Drugs" Antibiotics 10, no. 1: 53.
https://doi.org/10.3390/antibiotics10010053
APA Style
Benavent, E., Morata, L., Escrihuela-Vidal, F., Reynaga, E. A., Soldevila, L., Albiach, L., Pedro-Botet, M. L., Padullés, A., Soriano, A., & Murillo, O.
(2021). Long-Term Use of Tedizolid in Osteoarticular Infections: Benefits among Oxazolidinone Drugs. Antibiotics, 10(1), 53.
https://doi.org/10.3390/antibiotics10010053